Ketamine for Depression: An Update

Affiliations

¹ Mood and Anxiety Disorders Program, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York; Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: james.murrough@mssm.edu.

Comment

James W Murrough. Biol Psychiatry. 2016.

. 2016 Sep 15;80(6):416-418.

doi: 10.1016/j.biopsych.2016.07.005.

¹ Mood and Anxiety Disorders Program, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York; Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: james.murrough@mssm.edu.

No abstract available

Comment on

Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study.
Singh JB, Fedgchin M, Daly E, Xi L, Melman C, De Bruecker G, Tadic A, Sienaert P, Wiegand F, Manji H, Drevets WC, Van Nueten L. Singh JB, et al. Biol Psychiatry. 2016 Sep 15;80(6):424-431. doi: 10.1016/j.biopsych.2015.10.018. Epub 2015 Nov 3. Biol Psychiatry. 2016. PMID: 26707087 Clinical Trial.
Sex Differences in Effects of Ketamine on Behavior, Spine Density, and Synaptic Proteins in Socially Isolated Rats.
Sarkar A, Kabbaj M. Sarkar A, et al. Biol Psychiatry. 2016 Sep 15;80(6):448-456. doi: 10.1016/j.biopsych.2015.12.025. Epub 2016 Jan 11. Biol Psychiatry. 2016. PMID: 26957131 Free PMC article.
Bidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment.
Ren Z, Pribiag H, Jefferson SJ, Shorey M, Fuchs T, Stellwagen D, Luscher B. Ren Z, et al. Biol Psychiatry. 2016 Sep 15;80(6):457-468. doi: 10.1016/j.biopsych.2016.02.009. Epub 2016 Feb 13. Biol Psychiatry. 2016. PMID: 27062563 Free PMC article.